Dolby Laboratories (DLB) Cash from Financing Activities (2009 - 2026)

Dolby Laboratories has reported Cash from Financing Activities for 18 years, with the latest figure at -$99.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 53.96% year-over-year to -$99.9 million; the trailing twelve-month figure through Mar 2026 stood at -$346.5 million (down 43.8% YoY), and the FY2025 full-year result was -$247.2 million, up 14.1% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$99.9 million, up from -$121.8 million in the prior quarter.
• The five-year high for Cash from Financing Activities was -$36.8 million in Q2 2023, with the low at -$242.4 million in Q3 2022.
• Historically, Cash from Financing Activities has averaged -$90.1 million across 5 years, with a median of -$64.9 million in 2025.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 340.89% — and 2023, when it soared 82.35%.
• Dolby Laboratories' Cash from Financing Activities stood at -$90.1 million in 2022, then sank by 38.9% to -$125.1 million in 2023, then soared by 53.99% to -$57.6 million in 2024, then tumbled by 111.62% to -$121.8 million in 2025, then rose by 18.02% to -$99.9 million in 2026.
• The last three Cash from Financing Activities figures came in at -$99.9 million (Q1 2026), -$121.8 million (Q4 2025), and -$64.1 million (Q3 2025), per Business Quant data.